Chain Bridge I (CBRRF): Nasdaq/NYSE listing notice — Chain Bridge I securities downgraded from OTCQB to OTCID for public float non-compliance

Chain Bridge I

OTC Markets moved Chain Bridge I's securities from OTCQB to OTCID Basic Market on Feb 12, 2026, after cure period expired.
Cause: public float remained below 10% of total shares outstanding per OTCQB listing rule.
To be reinstated to OTCQB, company must increase public float to at least 10% and meet all OTCQB eligibility requirements.
Company continues SEC reporting and actively evaluating strategic options to regain compliance.
Transition to OTCID is not expected to impact business operations or SEC filing obligations.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Chain Bridge I received a otc delisting notice notice regarding other.

Exchange: otc
Notice: delisting notice

Exact text from the filing

February 11, 2026, the Company received a written notice from OTC indicating that the cure period has now expired. Consequently, the Company’s securities were moved from the OTCQB market to the OTCID Basic Market (“OTCID”) on February 12, 2026. OTC further notified the Company that if it would like to be moved back to OTCQB, it must increase public float to at least 10% of the total shares outstanding and meet all of the eligibility requirements under Section 1 of the OTCQB listing standards. The Company will continue to file its periodic reports and remain subject to the reporting obligations

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Chain Bridge I filing history →

Source: SEC EDGAR

accession 0001213900-26-018000

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.